A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469. [electronic resource]
- Pharmacogenetics and genomics Feb 2014
- 129-32 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1744-6880
10.1097/FPC.0000000000000023 doi
Aldehyde Oxidase--genetics Antineoplastic Agents--administration & dosage Clinical Trials, Phase I as Topic Cohort Studies Genetic Variation Genotype Humans Liver--metabolism Neoplasms--drug therapy Pharmacogenetics Polymorphism, Single Nucleotide Quantitative Trait Loci Quinoxalines--administration & dosage